腰高比与1型糖尿病冠心病风险相关:19年队列研究
该研究基于芬兰糖尿病肾病研究4349例无冠心病史的1型糖尿病患者,中位随访19年,发现中心性肥胖(腰高比≥0.5)与冠心病风险增加相关,腰高比每增加0.1单位风险比1.21,在无白蛋白尿者中关联更明显。
要点
- 腰高比≥0.5的1型糖尿病患者10年冠心病累积发病率11.6%,无中心性肥胖者4.4%。
- 腰高比每增加0.1单位,冠心病风险增加21%(HR 1.21,95%CI 1.06-1.38)。
- 无白蛋白尿者中腰高比与冠心病关联更强(HR 1.26,95%CI 1.02-1.56)。
核心结论
- 腰高比与1型糖尿病患者的冠心病风险增加相关,尤其在无白蛋白尿者中更明显。
研究设计与样本
- 芬兰糖尿病肾病研究队列,纳入4349例无既往冠心病史的1型糖尿病患者,中位随访19年。
主要发现
- 随访期间共发生664例冠心病事件(15.3%)。
- 中心性肥胖者10年和20年冠心病累积发病率分别为11.6%和25.3%,无中心性肥胖者分别为4.4%和9.9%。
- 多变量分析中,腰高比每增加0.1单位,冠心病风险比1.21(95%CI 1.06-1.38;P=0.006)。
- 无白蛋白尿者中,腰高比每增加0.1单位,冠心病风险比1.26(95%CI 1.02-1.56;P=0.03)。
关键数值与推荐
- 中心性肥胖定义为腰高比≥0.5。
- 结局包括急性心肌梗死、冠状动脉血运重建和冠心病相关死亡。
临床怎么用
- 对1型糖尿病患者应关注腰高比这一中心性肥胖指标,尤其无白蛋白尿者,以评估冠心病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes was investigated. Data on 4,349 individuals without prior CAD from the Finnish Diabetic Nephropathy Study were analyzed. Central obesity was defined as waist-to-height ratio (WHtR) ≥0.5. Outcomes included acute myocardial infarction, coronary revascularizations, and CAD-related death. Associations were assessed with Cox regression adjusted for baseline covariates. Over a median 19-year follow-up, 664 CAD events (15.3%) occurred. The 10- and 20-year cumulative CAD incidences were 11.6% and 25.3%, respectively, in those with central obesity versus 4.4% and 9.9% without, respectively. In multivariable analysis, the hazard ratio for CAD per 0.1-unit WHtR increase was 1.21 (95% CI, 1.06-1.38; P = 0.006) overall and 1.26 (95% CI, 1.02-1.56; P = 0.03) among those without albuminuria. In conclusion, WHtR is associated with increased CAD risk in type 1 diabetes, particularly among those without albuminuria.
引用
- Parente EB, Jansson Sigfrids F, Groop PH, et al. Waist-to-Height Ratio Is Associated With the Risk of Coronary Artery Disease in Type 1 Diabetes: A 19-Year Cohort Study. Diabetes Care. 2026. PMID: 41980064. doi:10.2337/dc25-2811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。